Search

Search Results
Results 481 - 490 of 939 for Abbreviate
  • Court rules in favor of Sandoz on Toprol Xl patent
    News - 26 Jul 2007
    Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a...
  • Lupin receives approval for Amlodipine tablets
    News - 18 Jul 2007
    Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate...
  • Barr confirms Xopenex patent challenge
    News - 17 Jul 2007
    Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex (Levalbuterol...
  • Caraco Pharmaceutical Labs announces FDA approval to market generic Tenormin
    News - 12 Jul 2007
    Caraco Pharmaceutical Laboratories has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Atenolol...
  • Approval of generic Dostinex
    News - 10 Jul 2007
    Barr Pharmaceuticals, Inc. has announced that its subsidiary Barr Laboratories, Inc. has received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a...
  • Mylan receives FDA approval for Ondansetron tablets
    News - 26 Jun 2007
    Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Applications (ANDAs) for Ondansetron Hydrochloride (HCl) Tablets, 4 mg...
  • Mylan receives FDA approval for Azithromycin tablets
    News - 1 Jun 2007
    Mylan Laboratories Inc. ( NYSE:MYL ) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug...
  • Lupin receives FDA approval for Ziprasidone Hydrochloride capsules
    News - 24 May 2007
    Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg,...
  • Lupin Pharmaceuticals receives FDA approval for Simvastatin tablets
    News - 16 May 2007
    Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
  • Caraco Pharmaceuticals to market generic Nimotop
    News - 30 Apr 2007
    Caraco Pharmaceutical Laboratories has announced that it will market Nimodipine Capsules, 30mg (Nimotop) on behalf of Sun Pharmaceutical Industries, Inc. (Sun), a wholly owned subsidiary of Sun...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback